Pot stocks are in the doldrums but affluent investors are upbeat.

Despite a bear market that’s seen the average cannabis stock lose more than half its value since March, 79 per cent of Canadians and 74 per cent of Americans still find the industry appealing, according to a new survey of 660 retail investors with at least $250,000 in investable assets.

The survey was commissioned by California-based omnichannel cannabis platform ManifestSeven and conducted by FTI Consulting Inc. It found that 90 per cent of Americans and 82 per cent of Canadians who are currently invested in cannabis believe they’re “completely on track” to achieve their financial goals despite the recent slump in markets.

Poor headwinds and outsized influence of individual investors have dropped valuations at multiple cannabis companies.

To understand why investors and financial analysts have cooled on the cannabis industry, just look at the jobs. Previously, marijuana businesses were all growth. If you needed a job and wanted to change fields, cannabis was fertile soil for a fresh start. While you can still find work in cannabis, the biggest players aren’t hiring like they used to.

An Ontario university is set to undertake a three-year study in treating dog cancer with cannabis.

The University of Guelph’s Ontario Veterinary College said in a news release Tuesday that the research could “help point the way to alternative pet therapies.” The study will focus on the efficacy of cannabidiol (CBD), a cannabis compound, in treating bladder cancer in canines, with particular focus on a common and “hard-to-treat” form known as urothelial carcinoma

Patsy Copus makes batches of pot-infused gummy bears or cannabis-coated chocolate strawberries every few weeks to help with her arthritis and other medical conditions.

Although cannabis edibles are expected to be sold legally in stores in December, the Windsor, Ont., resident said buying them will likely be a financial struggle.

Health Canada has capped the amount of the psychoactive compound tetrahydrocannabinol (THC) allowed in food and drinks to 10 milligrams — a restriction Copus said wouldn't meet the needs of some users.

"So for a person who has to take more of a higher dosage, that would be so expensive for them. They couldn't even afford it," said Copus, explaining cost is one of the reasons she makes her own edibles.

Young adults in Quebec who have become accustomed to visiting the province’s legal retail stores for their cannabis will soon no longer be allowed to do so.

Until now, the legal age to purchase marijuana in Quebec was 18 but as of January 1, 2020, Quebecers will have to wait until they turn 21. The new law makes Quebec the province with the highest legal age for cannabis consumption. The legal age for consumption across most of Canada is 19 with the exception of Alberta which has a legal age of 18.  

Anxiety is something every athlete, at every level, faces not only before competition, but sometimes just to get out the door.

Professional and amateurs alike suffer from nerves and, in the case of Percy Harvin, who played wide receiver for the Seattle Seahawks and won a Super Bowl, this left him breathless before taking the field. Harvin told the Bleacher Report he had seven prescriptions to calm his anxiety. Marijuana was the only thing that worked.

Marijuana legalization was supposed to give Canada's cannabis fanciers access to above board and reliable drug sources while providing tax revenue for the government. But one year in, large numbers of Canadian cannabis users continue to rely on underground dealers. Like with U.S. states that have grudgingly legalized marijuana for recreational use, the black market goes on thriving and generating profits because politicians and regulators have hobbled legal businesses and inconvenienced consumers through high taxes and excessive rules.

As a result, Canada's legal market is largely uncompetitive with the long-established black market there.

The Canadian marijuana stocks on our list could benefit most, at least in the short term, from the legalization of cannabis derivatives in Canada

SmallCapPower | October 28, 2019: On October 17, 2019, Canada legalized cannabis-derivative products, such as edibles, oils for vape pens, and beverages, in what investors have been calling Cannabis 2.0. Cannabis investors and speculators are hoping that Cannabis 2.0 will be the next big catalyst to move the share prices of these stocks higher. Today we have identified five Canadian marijuana stocks that are set to benefit most, at least in the short term, from the legalization of cannabis derivatives in Canada.

*Share prices at October 24, 2019, data obtained from S&P Capital IQ

Given the unpopularity of marijuana stocks these past few months, it's a relief when the rare piece of good news filters down into the industry. This happened last week, with official statistics in Canada -- one of the only countries in the world where recreational marijuana is legal nationwide -- showing substantial growth for the sixth month in a row.

Over the next decade, marijuana is projected to be one of the fastest growing industries. Having already more than tripled sales on a worldwide basis between 2014 and 2018 to $10.9 billion, the industry has some Wall Street forecasts calling for $50 billion, $75 billion, or even $200 billion in annual global weed sales by 2030. Figures like these are what make marijuana stocks such an attractive investment opportunity.